PACLITAXEL IN PERSISTANT/RECURRENT NONSQUAMOUS CELL CARCINOMA OF CERVIX/VAGINA

紫杉醇治疗宫颈/阴道持续性/复发性非鳞状细胞癌

• 批准号: 5218280
• 负责人: HARRISON G BALL
• 金额: --
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/5218280
• 关键词: carcinoma; cervix neoplasms; clinical research; clinical trials; drug screening /evaluation; female; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; paclitaxel; vagina neoplasms

Women with persistent or recurrent non-squamous cell carcinoma of the cervix and vagina following prior chemotherapy will be eligible for this study. The aims of this study are to estimate the antitumor activity of paclitaxel in patients with persistent or recurrent non-squamous cell carcinomas of the cervix and DES-associated clear cell adenocarcinoma of the vagina and cervix who have failed on higher priority protocols and to determine the nature and degree of toxicity of paclitaxel in this cohort of patients.

女性持续性或复发性非鳞状细胞癌 之前化疗后的宫颈和阴道将符合这一条件 学习。本研究的目的是评估其抗肿瘤活性。 紫杉醇治疗持续性或复发性非鳞状细胞癌 子宫颈癌和DES相关的透明细胞腺癌 在更高优先级的方案中失败的阴道和宫颈 目的：测定紫杉醇在体内的毒性性质和毒性程度。 一群病人。